
BioNet and BIA Separations collaborate to develop mRNA vaccines
BioNet and BIA Separations, now part of Sartorius, have developed an optimised mRNA manufacturing process. BIA’s expertise in chromatographic columns for mRNA purification combined with BioNet’s expertise in the product development of genetic vaccines have, since early 2021, enabled both teams to collaborate on the optimisation and upscale of a high-yield… Read More












